Pharming Group N.V. (PHAR)
NASDAQ·Healthcare·Biotechnology
$16.46
-2.72%
Mkt Cap $1.17B
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (3 analysts)
$39.50
Range $37.00 – $42.00
Implied Upside
+140.0%
Consensus $39.50 vs current $16.46
NASDAQ·Healthcare·Biotechnology
$16.46
-2.72%
Mkt Cap $1.17B
Buy
2
Hold
0
Sell
0
Price Target (3 analysts)
$39.50
Range $37.00 – $42.00
+140.0%
Consensus $39.50 vs current $16.46